Business Trends– category –
-
OPM Biosciences CHO Platform: 96% titer improvement specs
SelectScience UK Overview OPM Biosciences has expanded its OPM-CHO platform for biosimilar developers, launching a new Biosimilar Media Optimization Service and Sureness™ Biosimilar Platform. This service demonstrates an average titer im... -
N-1 Perfusion explained: 50% COGS reduction for BioProcess Tools
BioProcess Tools Unknown Overview A comparative analysis of upstream process intensification strategies revealed N-1 perfusion as a leading approach, reducing cost of goods sold (COGS) by 30-50% and increasing product titer by 85-100% wh... -
BioProcess Tools: 4-stage roadmap for 200,000L fermentation
BioProcess Tools USA Overview BioProcess Tools has unveiled a comprehensive four-stage scale-up strategy for precision fermentation, guiding processes from 10-liter lab scale to 200,000-liter commercial production over 3-6 years. This fr... -
Crush Dynamics: AI food fermentation specs for 30% energy cut
Food Navigator Canada Overview Canadian AgriTech firm Crush Dynamics has partnered with AI development company Atomic47 Labs to scale food fermentation processes using artificial intelligence. This collaboration aims to optimize the prod... -
Formo: FDA timeline for precision fermentation casein in 2026
Dairy Reporter Germany Overview German startup Formo is expected to receive a 'No Questions Letter' from the U.S. FDA regarding its GRAS assessment for precision-fermented casein within weeks, signaling its readiness for U.S. market entr... -
OXGENE: Minaris and Asimov AAV cell line manufacturing roadmap
PharmaSource USA Overview Minaris and Asimov have partnered to develop superior producer cell lines for AAV gene therapy manufacturing, combining Minaris' OXGENE viral vector technology with Asimov's synthetic biology platform. This coll... -
Äio and TFTAK Secure €1.94M for ‘DigiFoundry 2.0’ Project to Accelerate Waste-Derived Microbial Fat Production via AI-Driven Digital Platform
European Biotechnology Estonia Overview Äio and TFTAK have received €1.94 million in funding for their 'DigiFoundry 2.0' project, an AI-driven digital platform aimed at accelerating waste-derived microbial fat production. This three-year... -
BIANCA CLINIC Offers Autologous Adipose-Derived Stem Cell IV Therapy for Back Pain in Japan, Following Regenerative Medicine Regulatory Reforms
BIANCA CLINIC Japan Overview BIANCA CLINIC in Japan is offering intravenous (IV) therapy using autologous adipose-derived stem cells for back pain, aligning with Japan's legal framework reforms for regenerative medicine in 2025. This doc...
